Barlak, B. S. R. And İskender İzgi, B. 2024. Myrtucommulone-A augments the effects of cisplatin and epirubicin through the suppression of epithelial-mesenchymal transition-related markers in cancer cells. EACR The Tumour Ecosystem: Cellular Interactions and Therapeutic Opportunities , (Bergamo, Italy).

Barlak, B. S. R., & İskender İzgi, B., (2024). Myrtucommulone-A augments the effects of cisplatin and epirubicin through the suppression of epithelial-mesenchymal transition-related markers in cancer cells . EACR The Tumour Ecosystem: Cellular Interactions and Therapeutic Opportunities, Bergamo, Italy

Barlak, Bengi, And BANU İSKENDER İZGİ. "Myrtucommulone-A augments the effects of cisplatin and epirubicin through the suppression of epithelial-mesenchymal transition-related markers in cancer cells," EACR The Tumour Ecosystem: Cellular Interactions and Therapeutic Opportunities, Bergamo, Italy, 2024

Barlak, Bengi S. And İskender İzgi, BANU İ. . "Myrtucommulone-A augments the effects of cisplatin and epirubicin through the suppression of epithelial-mesenchymal transition-related markers in cancer cells." EACR The Tumour Ecosystem: Cellular Interactions and Therapeutic Opportunities , Bergamo, Italy, 2024

Barlak, B. S. R. And İskender İzgi, B. (2024) . "Myrtucommulone-A augments the effects of cisplatin and epirubicin through the suppression of epithelial-mesenchymal transition-related markers in cancer cells." EACR The Tumour Ecosystem: Cellular Interactions and Therapeutic Opportunities , Bergamo, Italy.

@conferencepaper{conferencepaper, author={Bengi Su Rumeysa Barlak And author={BANU İSKENDER İZGİ}, title={Myrtucommulone-A augments the effects of cisplatin and epirubicin through the suppression of epithelial-mesenchymal transition-related markers in cancer cells}, congress name={EACR The Tumour Ecosystem: Cellular Interactions and Therapeutic Opportunities}, city={Bergamo}, country={Italy}, year={2024}}